Atlas Trials

Sonrotoclax, Glofitamab, Gemcitabine, and Oxaliplatin for Relapsed or Refractory Large B-Cell Lymphoma

Clinical trial NCT07774234 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07774234
Sponsor
The First Affiliated Hospital of Soochow University
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Large B-Cell Lymphoma (LBCL)High-grade B-cell Lymphoma
Start date
2026-08-20
Primary completion
2028-12-31
Enrollment
39

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.